Top Markets
Coin of the day
AP Biosciences Inc AP Biosciences Inc

AP Biosciences Inc

6945
Rang în acțiuni #16379
AP Biosciences Inc. is a pioneering clinical-stage biopharmaceutical company... AP Biosciences Inc. is a pioneering clinical-stage biopharmaceutical company dedicated to the research and development of bispecific antibody drugs, aiming to fulfill critical unmet medical needs. Its robust pipeline features several promising candidates: Leading the pack, IBI302 is in Phase III clinical trials for the treatment of neovascular age-related macular degeneration (nAMD). Further along, AP505 is undergoing Phase I clinical trials for various solid tumors. AP203, also in Phase I, is being investigated for non-small cell lung cancer, head and neck squamous cell carcinoma, and esophageal squamous cell carcinomas. In earlier development, AP402 is currently in the pre-clinical research phase, focusing on breast cancer patients. Additionally, AP601 is also in pre-clinical research, targeting a broader spectrum of malignancies including lung cancer, pancreatic cancer, bladder cancer, ovarian cancer, and other solid tumors. Founded in 2013, the company maintains its headquarters in Taipei City, Taiwan.
Preț acțiune
$3.08
Capitalizare de piață
$299.18M
Schimbare (1 zi)
0.94%
Schimbare (1 an)
-20.61%
Țară
TW
Tranzacționează AP Biosciences Inc (6945)

Categorie

Istoric al prețului acțiunii pentru AP Biosciences Inc (6945)
Cel mai mare preț de închidere: $3.05 pe 2026-09-01

Cel mai mic preț de închidere: $2.10 pe 2023-07-01
Istoric al prețului acțiunii pentru AP Biosciences Inc din 2023 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -13.24%
2025 237.19%
2024 4.26%
2023 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$121.41 -10.62%
AU
$748.60 6.90%
CH